UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The transaction was disclosed in a document filed with the SEC, which is available at this link.

UnitedHealth Group Incorporated (NYSE:UNH) opened at 194.24 on Thursday. The company has a market cap of $187.80 billion, a price-to-earnings ratio of 23.33 and a beta of 0.64. The firm has a 50-day moving average of $191.01 and a 200-day moving average of $176.65. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04.

Get UnitedHealth Group Incorporated alerts:

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the prior year, the firm posted $1.96 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

COPYRIGHT VIOLATION WARNING: “Richard T. Burke Sells 15,000 Shares of UnitedHealth Group Incorporated (UNH) Stock” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/24/richard-t-burke-sells-15000-shares-of-unitedhealth-group-incorporated-unh-stock.html.

Several large investors have recently added to or reduced their stakes in the company. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group during the second quarter worth approximately $110,000. Bruderman Asset Management LLC bought a new stake in UnitedHealth Group during the second quarter worth approximately $114,000. Patriot Financial Group Insurance Agency LLC boosted its stake in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares in the last quarter. Finally, BDO Wealth Advisors LLC bought a new stake in UnitedHealth Group during the second quarter worth approximately $121,000. 86.21% of the stock is currently owned by hedge funds and other institutional investors.

Several brokerages have recently commented on UNH. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Cantor Fitzgerald reiterated an “overweight” rating and set a $208.00 price target on shares of UnitedHealth Group in a research report on Friday, July 21st. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price target for the company in a research report on Tuesday, May 30th. Jefferies Group LLC reiterated a “buy” rating and set a $192.00 price target on shares of UnitedHealth Group in a research report on Friday, May 19th. Finally, Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $205.00 price target (up previously from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. One investment analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $203.41.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.